Transient ischemic attack (TIA ... and the majority of published treatment guidelines are several years old. Newly updated evidence-based, unbiased guidelines sponsored by the National Stroke ...

A major shift in stroke care is underway as tenecteplase outperforms alteplase. This new treatment could redefine recovery ...

The newly approved treatment provides a fast-acting option for acute ischemic stroke (AIS) care. <li /> Administered as a ...

Lowering the body temperature of preterm infants (born at 33 to 35 weeks of pregnancy) with hypoxic ischemic encephalopathy ...

Whole-body hypothermia within hours of birth failed to improve outcomes in preterm infants less than 36 weeks' gestational ...

1 In its most severe form, critical limb ischemia patients are often treated with lower extremity amputation (LEA). 2 “We are dedicated to expanding innovative treatment options for peripheral ...

and its scientific rationale in the Company’s ongoing Phase 2/3 trial for acute ischemic stroke (ReMEDy2 Trial). DM199, a bradykinin-producing enzyme, represents a promising potential treatment ...

DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for severe ischemic diseases, today announced the peer-reviewed ...

Lowering the body temperature of preterm infants (born at 33 to 35 weeks of pregnancy) with hypoxic ischemic encephalopathy (HIE)—a type of brain damage caused by oxygen loss—offers no benefits over ...